Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Van Der Vliet HJ"'
Autor:
Lee KH, Seong HJ, Kim G, Jeong GH, Kim JY, Park H, Jung E, Kronbichler A, Eisenhut M, Stubbs B, Solmi M, Koyanagi A, Hong SH, Dragioti E, de Rezende LFM, Jacob L, Keum N, van der Vliet HJ, Cho E, Veronese N, Grosso G, Ogino S, Song M, Radua J, Jung SJ, Thompson T, Jackson SE, Smith L, Yang L, Hans Oh, Choi EK, Shin JI, Giovannucci EL, Gamerith G
Publikováno v:
ADV NUTR
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Multiple studies have suggested that ?-3 fatty acid intake may have a protective effect on cancer risk; however, its true association with cancer risk remains controversial. We performed an umbrella review of meta-analyses to summarize and evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::331bad66361399cdd4fe65bcdd08cde5
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17843
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17843
Autor:
Jeong GH, Lee KH, Lee IR, Oh JH, Kim DW, Shin JW, Kronbichler A, Eisenhut M, van der Vliet HJ, Abdel-Rahman O, Stubbs B, Solmi M, Veronese N, Dragioti E, Koyanagi A, Radua J, Shin JI
Publikováno v:
Journal of Clinical Medicine
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Capillary leak syndrome (CLS) is a rare disease with profound vascular leakage, which can be associated with a high mortality. There have been several reports on CLS as an adverse effect of anti-cancer agents and therapy, but the incidence of CLS acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::02dbc2059337fd7770bd04c3ceb140f8
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15749
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15749
Publikováno v:
van der Vliet, J J, van der Peet, D L & Verheul, H M W 2009, ' Case 19-2009: Carcinoma of the Gastroesophageal Junction ', New England Journal of Medicine, vol. 361, no. 13, pp. 1315-1315 . https://doi.org/10.1056/nejmc091434
New England Journal of Medicine, 361(13), 1315-1315. Massachussetts Medical Society
New England Journal of Medicine, 361(13), 1315-1315. Massachussetts Medical Society
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204444f635aca9f1d3a756167d8d85c4
https://research.vumc.nl/en/publications/843a82f9-f312-4275-b40f-0f0abfcb9d8b
https://research.vumc.nl/en/publications/843a82f9-f312-4275-b40f-0f0abfcb9d8b
Autor:
van der Vliet HJ, Johannes, Nishi, N, Koezuka, Y, von Blomberg BM, van den Eertwegh AJ, Alfonsus, Porcelli, S A, Pinedo, H M, Scheper, R J, Giaccone, G
Publikováno v:
Journal of Immunological Methods, 247(1-2), 61-72. Elsevier
van der Vliet HJ, Nishi, N, Koezuka, Y, von Blomberg BM,, van den Eertwegh AJ, Porcelli, S A, Pinedo, H M, Scheper, R J & Giaccone, G 2001, ' Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15 ', Journal of Immunological Methods, vol. 247, no. 1-2, pp. 61-72 .
van der Vliet HJ, Nishi, N, Koezuka, Y, von Blomberg BM,, van den Eertwegh AJ, Porcelli, S A, Pinedo, H M, Scheper, R J & Giaccone, G 2001, ' Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15 ', Journal of Immunological Methods, vol. 247, no. 1-2, pp. 61-72 .
Natural killer T (NKT) cells have an extremely restricted T-cell receptor repertoire, in man consisting of a Valpha24 chain preferentially paired with a Vbeta11 chain, and play crucial roles in various immune responses. Characterization of circulatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cbe3a7e9fe95a142810e73d9a70993c7
https://research.vumc.nl/en/publications/2af834f6-1608-439d-afee-066f53a99518
https://research.vumc.nl/en/publications/2af834f6-1608-439d-afee-066f53a99518
Autor:
Schneiders FL, de Bruin RC, van den Eertwegh AJ, Scheper RJ, Leemans CR, Brakenhoff RH, Langendijk JA, Verheul HM, de Gruijl TD, Molling JW, van der Vliet HJ
Publikováno v:
Journal of Clinical Oncology; 2/10/2012, Vol. 30 Issue 5, p567-570, 4p
Publikováno v:
New England Journal of Medicine. 9/24/2009, Vol. 361 Issue 13, p1315-1316. 2p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michielon E; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam.; Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Cancer Center Amsterdam, Cancer Biology and Immunology Program, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam., King LA; Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Cancer Center Amsterdam, Cancer Biology and Immunology Program, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Department of Medical Oncology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam., Waaijman T; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam.; Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam., Veth M; Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Cancer Center Amsterdam, Cancer Biology and Immunology Program, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Department of Medical Oncology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam., Spiekstra SW; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam.; Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam., van der Vliet HJ; Cancer Center Amsterdam, Cancer Biology and Immunology Program, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Department of Medical Oncology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam.; Lava Therapeutics NV, Utrecht., Gibbs S; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam.; Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Cancer Center Amsterdam, Cancer Biology and Immunology Program, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit, Amsterdam, The Netherlands., de Gruijl TD; Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Cancer Center Amsterdam, Cancer Biology and Immunology Program, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.; Department of Medical Oncology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam.
Publikováno v:
Immuno-oncology technology [Immunooncol Technol] 2024 Jul 10; Vol. 24, pp. 100724. Date of Electronic Publication: 2024 Jul 10 (Print Publication: 2024).
Autor:
Bakkerus L; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Subtil B; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Bontkes HJ; Department Laboratory Medicine, LGDO, Section Medical Immunology, Amsterdam, The Netherlands., Gootjes EC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Reijm M; Department Laboratory Medicine, LGDO, Section Medical Immunology, Amsterdam, The Netherlands., Vullings M; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Verrijp K; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Bokhorst JM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Woortman C; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Jonker MA; Department of IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands., van der Vliet HJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Verhoef C; Department of Surgery, ErasmusMC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Gorris MAJ; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Vries IJM; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Gruijl TD; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands., Buffart TE; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Tauriello DVF; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2024 Jun 10; Vol. 13 (1), pp. 2361971. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).
Autor:
de Haas AM; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Stolk DA; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Schetters STT; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Goossens-Kruijssen L; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Keuning E; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Ambrosini M; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; LIPOSOMA BV, Meerpaalweg 5, 1332 BB Almere, The Netherlands., Boon L; JJP Biologics, 00-728 Warsaw, Poland., Kalay H; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Storm G; LIPOSOMA BV, Meerpaalweg 5, 1332 BB Almere, The Netherlands.; Department of Biomaterials Science and Technology, University of Twente, 7500 AE Enschede, The Netherlands.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore., van der Vliet HJ; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.; LAVA Therapeutics, 3584 CM Utrecht, The Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., van Kooyk Y; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2024 Apr 24; Vol. 16 (5). Date of Electronic Publication: 2024 Apr 24.